Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on September 4, 2025
Dyadic to Present at Investor Conferences and BPI East
GlobeNewswire
·
September 4, 2025
JUPITER, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, …
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
GlobeNewswire
·
September 4, 2025
PITTSBURGH, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug development and discovery, and Every Cure, a leading nonprofit dedicated to identifying and validating new uses for existing drugs, today …
Mark Mikhael, CEO of Olympia and Wesley Pharmaceuticals, Named Pharmacist of the Year by the Florida Society of Health-System Pharmacists
GlobeNewswire
·
September 4, 2025
ORLANDO, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Recognized for his leadership in advancing compounding, championing patient access, and shaping the future of pharmacy, Mark Mikhael, PharmD, CEO of Olympia and Wesley Pharmaceuticals, has been named …
Cinq étudiants touchés par la SLA reçoivent la bourse Kevin Daly 2025 de la Société canadienne de la SLA
GlobeNewswire
·
September 4, 2025
TORONTO, 04 sept. 2025 (GLOBE NEWSWIRE) -- La Société canadienne de la SLA et le fonds Kevin Daly Bursary Fund sont fiers d’annoncer les récipiendaires de la bourse Kevin Daly 2025 de la Société canadienne de la SLA. Cette année, cinq étudiants de niveau …
VIVUS Showcases Leadership in Obesity Management at the 2025 International Congress on Obesity and MEtabolic Syndrome (ICOMES)
GlobeNewswire
·
September 4, 2025
— Presentations spotlight VIVUS’s 13-year track record of leadership with QSYMIA® (phentermine and topiramate extended-release capsules CIV) in the treatment of obesity and overweight CAMPBELL, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a …
Five students impacted by ALS receive the 2025 ALS Canada Kevin Daly Bursary
GlobeNewswire
·
September 4, 2025
TORONTO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The ALS Society of Canada (ALS Canada) and the Kevin Daly Bursary Fund are proud to announce the recipients of the 2025 ALS Canada Kevin Daly Bursary. This year, five post-secondary students with a personal …
“He’s No Prince” PSA Shatters Fairy Tale Illusions to Expose Emotional Abuse
GlobeNewswire
·
September 4, 2025
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- What if Prince Charming wasn’t so charming behind closed doors? The fourth and final installment of The Last I’m Sorry domestic violence awareness campaign, entitled “He’s No Prince” from Safe in Harm’s Way …
Raleigh Orthopaedic Implements Full Athelas Product Suite to Enhance Workflow Efficiency and Patient Care
GlobeNewswire
·
September 4, 2025
MOUNTAIN VIEW, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Athelas, a healthcare technology company powered by Commure, today announced the implementation of its full product suite with Raleigh Orthopaedic, a leading patient-centered orthopaedic practice in …
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), and Denali Capital Acquisition Corp. Announce Approval from Denali’s Shareholders of the Previously Announced Business…
GlobeNewswire
·
September 4, 2025
PALO ALTO, Calif, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur”), a majority-owned subsidiary of Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, …
BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
GlobeNewswire
·
September 4, 2025
SUNNYVALE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- - BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that BioCardia’s President and CEO, …
Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment
GlobeNewswire
·
September 4, 2025
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses the Company’s recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (“PoC 1”) THE WOODLANDS, TX, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Autonomix …
Bonafide® Health Announces Expansion to Retail with Exclusive Launch into 1,800+ Target Stores and Target.com
GlobeNewswire
·
September 4, 2025
New York, NY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a leading direct-to-consumer women’s healthcare company that provides clinically researched solutions to effectively relieve perimenopause …
Artelo Biosciences Announces Pricing of $3.0 Million Public Offering
GlobeNewswire
·
September 4, 2025
SOLANA BEACH, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic …
Branded Legacy, Inc. Expands Capabilities with Acquisition of State-of-the-Art GMP Facility in Vancouver
GlobeNewswire
·
September 4, 2025
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a pioneering biotechnology company dedicated to revolutionizing addiction treatment and harm reduction solutions, today announced that its …
BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 4, 2025
NESS ZIONA, Israel, Sept. 04, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE), a clinical-stage company advancing natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that Jonathan Solomon, the Company’s …
Sofwave Receives FDA, Pre-market Clearance for Pure Impact VIPTM Standalone EMS Device For Comprehensive Multi-Body Area Muscle Strengthening and Firming
GlobeNewswire
·
September 4, 2025
The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one independent unit Standalone device is launched with an enhanced Pure Impact™ feature set which provides comprehensive muscle …
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)
GlobeNewswire
·
September 4, 2025
Oral presentation will feature data demonstrating SCY-247 in vitro activity against C. auris strains, including isolates with mutations commonly associated with echinocandin-resistance Additional poster presentations highlight SCY-247’s broad spectrum of …
Sen. Debbie Stabenow, State Legislators to Highlight Annual Walk a Mile in My Shoes Rally & Warn Against State PIHP Procurement Process
GlobeNewswire
·
September 4, 2025
LANSING, Mich., Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Community Mental Health Association of Michigan (CMHAM) announces that former U.S. Senator Debbie Stabenow is this year’s keynote speaker at the Walk a Mile in My Shoes Rally, which will begin at 1:30 …
Fifty1 Labs, Inc. Leadership Publishes Landmark Framework to Unlock Global Oncology Data Through AI-Driven Real-World Evidence
GlobeNewswire
·
September 4, 2025
VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- via IBN – Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), announces the publication of a landmark technical primer on "transportability" methods in oncology real-world evidence …
Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease
GlobeNewswire
·
September 4, 2025
Novel human preclinical neuronal model for Parkinson’s disease demonstrated CNM-Au8’s ability to improve mitochondrial health, restore cellular metabolism, reduce inflammation, and normalize dysregulated gene expression in both familial and sporadic …